-2.52%
4.15%
9.65%
11.61%
-19.27%
-53.13%
154.56%
AI Spotlight on SECARE
Company Description
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells pet healthcare products.It offers ProDen PlaqueOff powder, a food supplement for cats and dogs, which reduce the formation of plaque and tartar; ProDen PlaqueOff dental bites, a pet dental product; ProDen PlaqueOff powder cat; ProDen PlaqueOff dental bones for dogs; ProDen PlaqueOff mini dental care bones, a chewy bone for smaller dogs; and ProDen PlaqueOff soft chews for dogs and cats.The company also provides dietary supplements for cats, dogs, and horses under the NutriScience brand, such as Glucosamine and Stomax used to renew joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid for joints and mobility; KalmAid, which helps to calm nervous dogs; and OmegaAid and RevitalAid, a feed supplement used for healthy skin and coat.
In addition, it develops and manufactures equine supplements, including Gastrocare used to relieve gastric pain and improve appetite; Equine Gold, which helps horse to thrive; ArthriAid used to aid horse's own natural manufacture of cartilage; and AnxiKalm, a supplement to calm excitable horses.Further, the company provides ProDen PlaqueOff teeth and gums, a natural food supplement to enhance dental hygiene and prevent tartar buildup for human.It distributes its products through pharmacies, veterinary clinics, pet shops, animal hospital, and online.
Swedencare AB (publ) was incorporated in 1993 and is headquartered in Malmö, Sweden.
Market Data
| Last Price | 50.2 |
| Change Percentage | -2.52% |
| Open | 50.7 |
| Previous Close | 51.5 |
| Market Cap ( Millions) | 7968 |
| Volume | 67970 |
| Year High | 67.98 |
| Year Low | 37.38 |
| M A 50 | 48.58 |
| M A 200 | 49.12 |
Financial Ratios
| FCF Yield | 4.25% |
| Dividend Yield | 0.46% |
| ROE | 0.83% |
| Debt / Equity | 20.96% |
| Net Debt / EBIDTA | 246.26% |
| Price To Book | 1.09 |
| Price Earnings Ratio | 128.59 |
| Price To FCF | 23.55 |
| Price To sales | 3.19 |
| EV / EBITDA | 17.06 |
News
- Jan -29 - 3 Growth Companies With High Insider Ownership To Watch
- Dec -26 - 3 Growth Stocks With Insider Ownership Reaching Up To 35%
- Nov -19 - OTC Markets Group Welcomes SWEDENCARE AB to OTCQX
- Nov -18 - November 2024's Leading Growth Companies With Significant Insider Ownership
- Oct -18 - 3 Swedish Growth Companies With High Insider Ownership Growing Revenues At 19%
- Sep -19 - Swedish Growth Companies With High Insider Ownership
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Nutraceuticals
Expected Growth : 10 %
What the company do ?
Nutraceuticals from Swedencare AB (publ) refers to dietary supplements and functional foods that provide health benefits, manufactured by Swedencare AB, a Swedish company.
Why we expect these perspectives ?
Swedencare AB's 10% growth in Nutraceuticals is driven by increasing demand for natural health products, expanding e-commerce channels, and strategic partnerships. The company's strong brand portfolio, including Probi and Nutravet, also contributes to growth. Furthermore, the rising awareness of preventative healthcare and pet humanization trends support the segment's expansion.
Segment n°2 -> Topicals/Dermatology
Expected Growth : 11 %
What the company do ?
Topicals/Dermatology from Swedencare AB (publ) refers to a range of skincare products and treatments for various skin conditions, including acne, eczema, and psoriasis.
Why we expect these perspectives ?
Strong demand for natural and organic skincare products, increasing awareness of skin health, and rising prevalence of skin conditions drive growth in Topicals/Dermatology segment. Swedencare AB's (publ) innovative product offerings, strategic partnerships, and expanding distribution channels further fuel the 11% growth.
Segment n°3 -> ProDen PlaqueOff
Expected Growth : 9 %
What the company do ?
ProDen PlaqueOff is a pet dental product from Swedencare AB, a natural, easy-to-use powder that helps reduce plaque, tartar, and bad breath in dogs and cats.
Why we expect these perspectives ?
ProDen PlaqueOff's 9% growth is driven by increasing pet humanization, rising awareness of pet oral health, and growing demand for natural, vegan, and eco-friendly products. Swedencare AB's strong distribution network, strategic partnerships, and effective marketing strategies also contribute to the segment's growth.
Segment n°4 -> Other
Expected Growth : 8 %
What the company do ?
Other from Swedencare AB (publ) refers to the remaining business segment, excluding Animal Health and Human Care, comprising miscellaneous products and services.
Why we expect these perspectives ?
Swedencare AB's 8% growth is driven by increasing pet owners' willingness to spend on premium pet care, expansion into new markets, and strategic acquisitions. The company's focus on e-commerce and digital marketing has also contributed to its growth, along with the rising demand for pet health and wellness products.
Segment n°5 -> Pharma
Expected Growth : 13 %
What the company do ?
Pharma from Swedencare AB (publ) is a Swedish company that develops and commercializes pharmaceutical products for human and animal health.
Why we expect these perspectives ?
Swedencare AB's 13% growth in Pharma segment is driven by increasing demand for pet health products, strategic acquisitions, and expansion into new markets. Strong product portfolio, including NutriPlus and PetMD, contributes to revenue growth. Additionally, investments in e-commerce and digital marketing enhance customer reach and engagement, further fueling growth.
Swedencare Ab (Publ) Products
| Product Range | What is it ? |
|---|---|
| ProDen PlaqueOff | A dietary supplement for pets that helps to reduce plaque, tartar and bad breath |
| ProDen PlaqueOff Powder | A powder supplement for pets that helps to reduce plaque, tartar and bad breath |
| Dental Vet | A range of dental care products for pets, including toothpaste, toothbrushes and dental chews |
| NutriPlus | A range of nutritional supplements for pets, including omega-3 fatty acids and antioxidants |
| PetAccord | A range of natural supplements for pets, including calming aids and joint support |
Swedencare AB (publ)'s Porter Forces
Threat Of Substitutes
The threat of substitutes for Swedencare AB (publ) is medium due to the presence of alternative healthcare services and products.
Bargaining Power Of Customers
The bargaining power of customers for Swedencare AB (publ) is low due to the company's strong brand reputation and customer loyalty.
Bargaining Power Of Suppliers
The bargaining power of suppliers for Swedencare AB (publ) is medium due to the company's dependence on a few key suppliers for raw materials.
Threat Of New Entrants
The threat of new entrants for Swedencare AB (publ) is low due to the high barriers to entry in the healthcare industry, including regulatory hurdles and high capital requirements.
Intensity Of Rivalry
The intensity of rivalry for Swedencare AB (publ) is high due to the competitive nature of the healthcare industry, with many established players competing for market share.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 17.03% |
| Debt Cost | 7.80% |
| Equity Weight | 82.97% |
| Equity Cost | 9.15% |
| WACC | 8.92% |
| Leverage | 20.52% |
Swedencare AB (publ) : Quality Control
Swedencare AB (publ) passed 5 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| PSG.DE | PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream … |
| VETO.PA | Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas … |
| PPGN.SW | PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, … |
| RJF.MC | Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include … |
| BOI.PA | Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Reig Jofre
A-Score
1-Year Total Return ->
🥈
PharmaSGP Holding
A-Score
1-Year Total Return ->
🥉
Boiron
A-Score
1-Year Total Return ->
4
Vetoquinol
A-Score
1-Year Total Return ->
5
PolyPeptide
A-Score
1-Year Total Return ->
6
